Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 16, 2023

SELL
$0.64 - $1.45 $27,712 - $62,785
-43,300 Reduced 54.19%
36,600 $25,000
Q4 2022

Feb 14, 2023

SELL
$1.1 - $1.74 $64,240 - $101,616
-58,400 Reduced 42.23%
79,900 $87,000
Q3 2022

Nov 14, 2022

BUY
$1.53 - $2.77 $62,118 - $112,462
40,600 Added 41.56%
138,300 $243,000
Q2 2022

Aug 15, 2022

BUY
$0.91 - $2.34 $39,858 - $102,492
43,800 Added 81.26%
97,700 $152,000
Q1 2022

May 16, 2022

SELL
$1.98 - $5.01 $69,498 - $175,851
-35,100 Reduced 39.44%
53,900 $107,000
Q4 2021

Feb 14, 2022

BUY
$4.58 - $17.14 $407,620 - $1.53 Million
89,000 New
89,000 $414,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Better Therapeutics, Inc.


  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.